0001585521-23-000249 | 10-Q | XBRL Viewer | Zoom Video Communications INC

Print Document View Excel Document

Restructuring Activities - Schedule of Restructuring Costs (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Oct. 31, 2023	Oct. 31, 2023
Restructuring Cost and Reserve [Line Items]
Total restructuring expenses	$ 0	$ 72,993
Cost of revenue
Restructuring Cost and Reserve [Line Items]
Total restructuring expenses		7,119
Research and development
Restructuring Cost and Reserve [Line Items]
Total restructuring expenses		19,629
Sales and marketing
Restructuring Cost and Reserve [Line Items]
Total restructuring expenses		32,930
General and administrative
Restructuring Cost and Reserve [Line Items]
Total restructuring expenses		$ 13,315

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Summary of Business and Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) and applicable regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting, and include the accounts of Zoom Video Communications, Inc., its subsidiaries, and variable interest entities for which we are the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated balance sheet as of January 31, 2023 included herein was derived from the audited financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. The unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets, statements of operations, statements of comprehensive income, statements of stockholders’ equity, and statements of cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the estimated expected benefit period for deferred contract acquisition costs, stock-based compensation expense, the fair value of marketable securities, acquired intangible assets and goodwill, the valuation of deferred income tax assets and uncertain tax positions, and accruals and contingencies. Actual results could materially differ from those estimates.

Stockholders’ Equity and Equity Incentive Plans - Schedule of Restricted Stock Units Activity Under Equity Incentive Plan (Details) - RSUs	9 Months Ended
	Oct. 31, 2023 $ / shares shares
RSUs
Beginning balance (in shares) \| shares	21,868,533
Granted (in shares) \| shares	17,141,593
Vested (in shares) \| shares	(8,747,679)
Cancelled/forfeited (in shares) \| shares	(3,772,653)
Ending balance (in shares) \| shares	26,489,794
Weighted- Average Grant Date Fair Value Per Share
Beginning balance (in dollars per share) \| $ / shares	$ 109.31
Granted (in dollars per share) \| $ / shares	69.01
Vested (in dollars per share) \| $ / shares	105.71
Cancelled/forfeited (in dollars per share) \| $ / shares	102.10
Ending balance (in dollars per share) \| $ / shares	$ 85.46

Net Income Per Share Attributable to Common Stockholders - Schedule of Potential Shares of Common Stock Excluded from Computation of Diluted Net Income Per Share Attributable to Common Stockholders (Details) - shares	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Class A
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	9,544,793	15,262,056	11,453,915	9,194,453
Class A \| Unvested RSUs
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	7,869,069	12,741,748	9,345,635	7,656,321
Class A \| Purchase rights committed under the ESPP
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	1,573,013	2,395,761	1,996,477	1,462,148
Class A \| Outstanding stock options
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	102,711	124,547	111,803	75,984
Class A \| Held for charitable contributions
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)			405,156	405,156
Class B
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	0	0	0
Class B \| Unvested RSUs
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	0	0	0
Class B \| Purchase rights committed under the ESPP
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	0	0	0
Class B \| Outstanding stock options
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	0	0	0

Balance Sheet Components

9 Months Ended

Oct. 31, 2023

Balance Sheet Components [Abstract]

Balance Sheet Components

Accounts Receivable, Net

Accounts receivable are recorded for invoiced amounts and amounts for which revenue has been recognized, but not invoiced, net of allowances. Our short-term accounts receivable consist of the following:


	As of
	October 31, 2023		January 31, 2023

	(in thousands)
Accounts receivable, gross	$	553,697	$	590,610
Less: allowance for credit losses	(33,329)		(24,900)
Less: allowance for returns	(6,323)		(8,306)
Accounts receivable, net	$	514,045	$	557,404

Below is a rollforward of our allowance for credit losses for the nine months ended October 31, 2023 and 2022:




	2023		2022
	(in thousands)
Balance as of January 31	$	24,900	$	17,000
Provision for credit losses	39,397		34,610
Write-offs	(30,968)		(27,265)
Balance as of October 31	$	33,329	$	24,345

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following:


	As of
	October 31, 2023		January 31, 2023

	(in thousands)
Prepaid expenses	$	233,494	$	123,493
Other receivables	23,531		17,142
Restricted cash from international employee stock sales	4,972		13,141
Other	9,131		9,316
Prepaid expenses and other current assets	$	271,128	$	163,092

Property and Equipment, Net

Property and equipment consisted of the following:


	As of
	October 31, 2023		January 31, 2023

	(in thousands)
Servers	$	333,665	$	249,776
Software	92,055		84,082
Computer and office equipment	43,869		48,325
Leasehold improvements	35,785		25,948
Furniture and fixtures	3,335		4,372
Property and equipment, gross	508,709		412,503
Less: accumulated depreciation and amortization	(216,865)		(159,682)
Property and equipment, net	$	291,844	$	252,821

Depreciation and amortization expense was $23.5 million and $19.9 million for the three months ended October 31, 2023 and 2022, respectively, and $68.1 million and $54.6 million for the nine months ended October 31, 2023 and 2022, respectively.

Other Assets, Noncurrent

Other assets, noncurrent consisted of the following:


	As of
	October 31, 2023		January 31, 2023

	(in thousands)
Accounts receivable, noncurrent	$	31,025	$	92,031

Intangible assets subject to amortization, net	50,335		31,420
Indefinite-lived intangible assets	25,239		25,239
Prepaid expenses, noncurrent	24,445		9,695


Other	12,248		19,489
Other assets, noncurrent	$	143,292	$	177,874

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following:


	As of
	October 31, 2023		January 31, 2023

	(in thousands)

Accrued expenses	$	154,121	$	160,189
Accrued compensation and benefits	163,768		139,105
Income tax liabilities	17,333		46,441
Sales and other non-income tax liabilities	28,226		33,859
Customer deposit liabilities	40,733		33,640
Operating lease liabilities, current	23,904		22,790


Other	13,387		21,692
Accrued expenses and other current liabilities	$	441,472	$	457,716

Other Liabilities, Noncurrent

Other liabilities, noncurrent consisted of the following:


	As of
	October 31, 2023		January 31, 2023

	(in thousands)
Sales and other non-income tax liabilities	$	44,412	$	42,321



Other	32,449		24,874
Other liabilities, noncurrent	$	76,861	$	67,195

Investments - Schedule of Strategic Investments (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Measurement Alternative	$ 187,532	$ 118,763
Equity Method	95,975	93,854
Total equity securities	349,231	384,592
Debt securities	3,791	14,400
Fair value of strategic investments	69,515	186,375
Total strategic investments	353,022	398,992
Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities	65,724	171,975
Debt securities	$ 3,791	$ 14,400

Income Taxes - Schedule of Provision for Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Income Tax Disclosure [Abstract]
Income before provision for income taxes	$ 185,826	$ 54,749	$ 479,429	$ 288,820
Provision for income taxes	$ 44,614	$ 6,396	$ 140,799	$ 81,059
Effective tax rate	24.00%	11.70%	29.40%	28.10%

- Definition

Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(11))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-31

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 25
-Paragraph 1
-SubTopic 20
-Topic 940
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481913/940-20-25-1

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

+ Details

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details

Business Combinations	9 Months Ended
Business Combinations	Oct. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Business Combinations	Business Combinations Solvvy, Inc. On May 19, 2022, we acquired 100% of the issued and outstanding share capital of Solvvy, Inc., a private technology company specializing in customer support automation, for an all-cash purchase consideration of $121.2 million. The acquisition adds to our customer service capabilities and enhances our integrated platform by providing conversational AI capabilities. The acquisition has been accounted for as a business combination. In allocating the purchase consideration, $95.0 million was attributed to goodwill, $26.7 million to intangible assets (consisting of $12.0 million to developed technology and $14.7 million to customer relationships), and $0.5 million to other net liabilities acquired. The goodwill amount represents synergies related to our existing products expected to be realized from the acquisition and assembled workforce. The associated goodwill is not deductible for tax purposes. At the date of the acquisition, the developed technology and customer relationships both had an estimated useful life of 5.0 years, and both are amortized using the straight-line method over their respective estimated useful lives. As of October 31, 2023, the developed technology and customer relationships both had a remaining useful life of 3.5 years. Transaction costs incurred in connection with the acquisition were immaterial. The results of operations of Solvvy, Inc., which are not material, have been included in our condensed consolidated financial statements from the date of the acquisition. Pro forma and historical results of operations of the company have not been presented, as the results do not have a material effect on any of the periods presented in our condensed consolidated statements of operations. Workvivo Limited On April 21, 2023, we acquired 100% of the issued and outstanding share capital of Workvivo Limited (“Workvivo”), a private technology company that provides an employee experience platform, for an all-cash purchase consideration of $221.8 million. The acquisition extends our platform and offers our customers new ways to keep employees informed, engaged, and connected. The acquisition has been accounted for as a business combination. In allocating the purchase consideration, $184.7 million was attributed to goodwill, $28.0 million to intangible assets (primarily consisting of $10.8 million to developed technology and $17.0 million to customer relationships), and $9.1 million to other net assets acquired. The goodwill amount represents synergies related to our existing products expected to be realized from the acquisition and assembled workforce. The associated goodwill is not deductible for tax purposes. At the date of the acquisition, the developed technology and customer relationships both had an estimated useful life of 5.0 years, and both are amortized using the straight-line method over their respective estimated useful lives. As of October 31, 2023, the developed technology and customer relationships both had a remaining useful life of 4.5 years. Transaction costs incurred in connection with the acquisition were immaterial. The results of operations of Workvivo, which are not material, have been included in our condensed consolidated financial statements from the date of the acquisition. Pro forma and historical results of operations of the company have not been presented, as the results do not have a material effect on any of the periods presented in our condensed consolidated statements of operations. Uncertain tax positions are initially established in connection with the acquisition as of the acquisition date. We continue to collect information and reevaluate these estimates and assumptions quarterly. We will record any adjustments to our preliminary estimates to goodwill, provided that it is within the one-year measurement period.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Retained Earnings
Beginning balance (in shares) at Jan. 31, 2022		299,037,805
Beginning balance at Jan. 31, 2022	$ 5,780,018	$ 299	$ 3,749,514	$ (17,902)	$ 2,048,107
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		1,087,238
Issuance of common stock upon exercise of stock options	7,052	$ 1	7,051
Issuance of common stock upon release of restricted stock units (in shares)		2,865,551
Issuance of common stock upon release of restricted stock units	0	$ 3	(3)
Issuance of common stock for employee stock purchase plan (in shares)		373,259
Issuance of common stock for employee stock purchase plan	34,604		34,604
Repurchases of common stock (in shares)		(11,044,500)
Repurchases of common stock	(990,778)	$ (11)	(990,767)
Stock-based compensation expense	771,969		771,969
Other comprehensive income (loss)	(54,814)			(54,814)
Net income	207,761				207,761
Ending balance (in shares) at Oct. 31, 2022		292,319,353
Ending balance at Oct. 31, 2022	5,755,812	$ 292	3,572,368	(72,716)	2,255,868
Beginning balance (in shares) at Jul. 31, 2022		298,086,507
Beginning balance at Jul. 31, 2022	5,990,397	$ 298	3,830,745	(48,161)	2,207,515
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		229,183
Issuance of common stock upon exercise of stock options	1,809		1,809
Issuance of common stock upon release of restricted stock units (in shares)		959,192
Issuance of common stock upon release of restricted stock units	0	$ 1	(1)
Repurchases of common stock (in shares)		(6,955,529)
Repurchases of common stock	(564,832)	$ (7)	(564,825)
Stock-based compensation expense	304,640		304,640
Other comprehensive income (loss)	(24,555)			(24,555)
Net income	48,353				48,353
Ending balance (in shares) at Oct. 31, 2022		292,319,353
Ending balance at Oct. 31, 2022	5,755,812	$ 292	3,572,368	(72,716)	2,255,868
Beginning balance (in shares) at Jan. 31, 2023		293,822,850
Beginning balance at Jan. 31, 2023	$ 6,206,607	$ 294	4,104,880	(50,385)	2,151,818
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	1,214,532	1,214,532
Issuance of common stock upon exercise of stock options	$ 8,336	$ 1	8,335
Issuance of common stock upon release of restricted stock units (in shares)		8,747,679
Issuance of common stock upon release of restricted stock units	0	$ 9	(9)
Issuance of common stock for employee stock purchase plan (in shares)		552,904
Issuance of common stock for employee stock purchase plan	32,513	$ 1	32,512
Stock-based compensation expense	804,039		804,039
Other comprehensive income (loss)	23,276			23,276
Net income	338,630				338,630
Ending balance (in shares) at Oct. 31, 2023		304,337,965
Ending balance at Oct. 31, 2023	7,413,401	$ 305	4,949,757	(27,109)	2,490,448
Beginning balance (in shares) at Jul. 31, 2023		300,956,027
Beginning balance at Jul. 31, 2023	7,002,352	$ 302	4,689,521	(36,707)	2,349,236
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		169,610
Issuance of common stock upon exercise of stock options	650		650
Issuance of common stock upon release of restricted stock units (in shares)		3,212,328
Issuance of common stock upon release of restricted stock units	0	$ 3	(3)
Stock-based compensation expense	259,589		259,589
Other comprehensive income (loss)	9,598			9,598
Net income	141,212				141,212
Ending balance (in shares) at Oct. 31, 2023		304,337,965
Ending balance at Oct. 31, 2023	$ 7,413,401	$ 305	$ 4,949,757	$ (27,109)	$ 2,490,448

Restructuring Activities

9 Months Ended

Oct. 31, 2023

Restructuring and Related Activities [Abstract]

Restructuring Activities

On February 7, 2023, we announced a restructuring plan (the “Plan”) intended to reduce operating costs and continue advancing our ongoing commitment to profitable growth. The Plan included a reduction of our then-current workforce by approximately 15%.

The execution of the Plan was completed as of July 31, 2023, and therefore no restructuring expense was recorded for the three months ended October 31, 2023. For the nine months ended October 31, 2023, we recorded net restructuring costs of $73.0 million, which consisted of $54.4 million related to employee transition, severance payments, and employee benefits; $17.3 million related to stock-based compensation awards; and $1.3 million for other related expenses.

The following table summarizes our restructuring expenses that were recorded as an operating expense in the condensed consolidated statement of operations for the nine months ended October 31, 2023:


	Nine Months Ended October 31, 2023
	(in thousands)
Cost of revenue	$	7,119
Research and development	19,629
Sales and marketing	32,930
General and administrative	13,315
Total restructuring expenses	$	72,993

The following table summarizes our restructuring liability that is included in accrued expenses and other current liabilities on the condensed consolidated balance sheet:


	Severance and termination benefits		Other
	(in thousands)
Balance as of January 31, 2023	$	—	$	—
Restructuring expenses	54,361		1,339
Cash payments	(54,361)		(1,339)
Balance as of October 31, 2023	$	—	$	—

Revenue Recognition - Contract Balances (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022	Jan. 31, 2023
Revenue from Contract with Customer [Abstract]
Unbilled contracts receivable	$ 132.3		$ 132.3		$ 91.6
Revenue recognized included in deferred revenue	$ 600.8	$ 586.1	$ 1,159.6	$ 1,058.7

Investments

9 Months Ended

Oct. 31, 2023

Investments, Debt and Equity Securities [Abstract]

Investments

Marketable Securities

As of October 31, 2023 and January 31, 2023, our marketable securities consisted of the following:


	As of October 31, 2023
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value

	(in thousands)





Commercial paper	$	56,098	$	—	$	—	$	56,098
Agency bonds	1,608,658		4		(11,879)		1,596,783
Corporate and other debt securities	590,977		41		(4,231)		586,787
U.S. government agency securities	2,731,636		19		(19,879)		2,711,776
Treasury bills	50,068		—		(5)		50,063
Marketable securities	$	5,037,437	$	64	$	(35,994)	$	5,001,507


	As of January 31, 2023
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value

	(in thousands)


Commercial paper	$	77,701	$	—	$	—	$	77,701
Agency bonds	823,027		63		(12,440)		810,650
Corporate and other debt securities	555,354		385		(4,845)		550,894
U.S. government agency securities	2,910,572		150		(49,507)		2,861,215
Treasury bills	25,404		1		(29)		25,376
Marketable securities	$	4,392,058	$	599	$	(66,821)	$	4,325,836

Unrealized losses for securities that have been in an unrealized loss position for less than 12 months were $22.1 million and $24.8 million as of October 31, 2023 and January 31, 2023, respectively. Unrealized losses for securities that have been in an unrealized loss position for 12 months or longer were $13.9 million and $42.0 million as of October 31, 2023 and January 31, 2023, respectively. We review the individual securities that have unrealized losses on a regular basis to evaluate whether or not any security has experienced, or is expected to experience, credit losses resulting in the decline in fair value. We evaluate, among other factors, whether we have the intention to sell any of these marketable securities and whether it is more likely than not that we will be required to sell any of them before recovery of the amortized cost basis. We have not recorded an allowance for credit losses, as we believe any such losses would be immaterial based on the high-grade credit rating for each of our marketable securities as of the end of each period. There were no material realized gains or losses from available-for-sale securities that were reclassified out of accumulated other comprehensive loss for the three and nine months ended October 31, 2023 and 2022.

The following table presents the contractual maturities of our marketable securities as of October 31, 2023 and January 31, 2023:


	As of
	October 31, 2023		January 31, 2023

	(in thousands)
Less than one year	$	2,774,308	$	2,743,677
Due in one to five years	2,227,199		1,582,159
Total	$	5,001,507	$	4,325,836

Strategic Investments

Strategic investments by form and measurement category as of October 31, 2023 were as follows:


	Measurement Category
	Fair Value		Measurement Alternative		Equity Method		Total

	(in thousands)
Equity securities	$	65,724	$	187,532	$	95,975	$	349,231
Debt securities	3,791		—		—		3,791
Strategic investments	$	69,515	$	187,532	$	95,975	$	353,022

Strategic investments by form and measurement category as of January 31, 2023 were as follows:


	Measurement Category
	Fair Value		Measurement Alternative		Equity Method		Total

	(in thousands)
Equity securities	$	171,975	$	118,763	$	93,854	$	384,592
Debt securities	14,400		—		—		14,400
Strategic investments	$	186,375	$	118,763	$	93,854	$	398,992

During the nine months ended October 31, 2023, we made a total of $52.8 million of strategic investments in equity securities of private companies. Based on the terms of these privately-held securities, we determined that we do not have a controlling interest nor the ability to exercise significant influence over the operating and financial policies of the investees. Therefore these investments are currently accounted for under the measurement alternative method.

In the second quarter of fiscal year 2024, we sold a total of $107.2 million of strategic investments in equity securities of public companies. The gains on sale, which were not material, were recorded through gains (losses) on strategic investments, net in the condensed consolidated statements of operations.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Statement of Comprehensive Income [Abstract]
Unrealized gain (loss) on available for sale marketable securities, tax effect	$ (2,892)	$ 7,802	$ (7,013)	$ 17,417

Investments (Tables)

9 Months Ended

Oct. 31, 2023

Investments, Debt and Equity Securities [Abstract]

Schedule of Marketable Securities

As of October 31, 2023 and January 31, 2023, our marketable securities consisted of the following:


	As of October 31, 2023
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value

	(in thousands)





Commercial paper	$	56,098	$	—	$	—	$	56,098
Agency bonds	1,608,658		4		(11,879)		1,596,783
Corporate and other debt securities	590,977		41		(4,231)		586,787
U.S. government agency securities	2,731,636		19		(19,879)		2,711,776
Treasury bills	50,068		—		(5)		50,063
Marketable securities	$	5,037,437	$	64	$	(35,994)	$	5,001,507


	As of January 31, 2023
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value

	(in thousands)


Commercial paper	$	77,701	$	—	$	—	$	77,701
Agency bonds	823,027		63		(12,440)		810,650
Corporate and other debt securities	555,354		385		(4,845)		550,894
U.S. government agency securities	2,910,572		150		(49,507)		2,861,215
Treasury bills	25,404		1		(29)		25,376
Marketable securities	$	4,392,058	$	599	$	(66,821)	$	4,325,836

Schedule of Contractual Maturities of Marketable Securities

The following table presents the contractual maturities of our marketable securities as of October 31, 2023 and January 31, 2023:


	As of
	October 31, 2023		January 31, 2023

	(in thousands)
Less than one year	$	2,774,308	$	2,743,677
Due in one to five years	2,227,199		1,582,159
Total	$	5,001,507	$	4,325,836

Schedule of Strategic Investments

Strategic investments by form and measurement category as of October 31, 2023 were as follows:


	Measurement Category
	Fair Value		Measurement Alternative		Equity Method		Total

	(in thousands)
Equity securities	$	65,724	$	187,532	$	95,975	$	349,231
Debt securities	3,791		—		—		3,791
Strategic investments	$	69,515	$	187,532	$	95,975	$	353,022

Strategic investments by form and measurement category as of January 31, 2023 were as follows:


	Measurement Category
	Fair Value		Measurement Alternative		Equity Method		Total

	(in thousands)
Equity securities	$	171,975	$	118,763	$	93,854	$	384,592
Debt securities	14,400		—		—		14,400
Strategic investments	$	186,375	$	118,763	$	93,854	$	398,992

- Definition

Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-9

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-3

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-2

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-2

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-2

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (aa)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-2

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (aaa)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-2

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-2

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-3

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-3

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-3

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481800/320-10-50-3

+ Details

Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Balance Sheet Components [Abstract]
Accrued expenses	$ 154,121	$ 160,189
Accrued compensation and benefits	163,768	139,105
Income tax liabilities	17,333	46,441
Sales and other non-income tax liabilities	28,226	33,859
Customer deposit liabilities	40,733	33,640
Operating lease liabilities, current	23,904	22,790
Other	13,387	21,692
Accrued expenses and other current liabilities	$ 441,472	$ 457,716

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Cash flows from operating activities:
Net income	$ 338,630	$ 207,761
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	802,788	767,693
Amortization of deferred contract acquisition costs	203,908	186,626
Depreciation and amortization	77,179	57,921
Deferred income taxes	20,056	0
(Gains) losses on strategic investments, net	(8,474)
(Gains) losses on strategic investments, net		78,014
Provision for accounts receivable allowances	29,062	39,580
Unrealized foreign exchange losses	23,281	40,884
Non-cash operating lease cost	15,841	16,949
Amortization of discount/premium on marketable securities	(33,307)	4,156
Other	(5,251)	1,044
Changes in operating assets and liabilities:
Accounts receivable	71,993	(238,020)
Prepaid expenses and other assets	(124,455)	(163,721)
Deferred contract acquisition costs	(146,354)	(217,822)
Accounts payable	(2,258)	24,561
Accrued expenses and other liabilities	(15)	116,391
Deferred revenue	1,918	174,325
Operating lease liabilities, net	(16,931)	(17,668)
Net cash provided by operating activities	1,247,611	1,078,674
Cash flows from investing activities:
Purchases of marketable securities	(2,963,597)	(1,927,049)
Maturities of marketable securities	2,358,078	2,137,875
Purchases of property and equipment	(108,413)	(75,568)
Purchases of strategic investments	(52,800)	(65,050)
Proceeds from strategic investments	107,244	300
Cash paid for acquisition, net of cash acquired	(204,918)	(120,553)
Purchases of intangible assets	0	(10,568)
Net cash used in investing activities	(864,406)	(60,613)
Cash flows from financing activities:
Proceeds from exercise of stock options	8,336	6,815
Proceeds from issuance of common stock for employee stock purchase plan	32,513	34,605
Proceeds from employee equity transactions (remitted) to be remitted to employees and tax authorities, net	(4,897)	671
Cash paid for repurchases of common stock	0	(990,778)
Net cash provided by (used in) financing activities	35,952	(948,687)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(21,273)	(36,639)
Net increase (decrease) in cash, cash equivalents, and restricted cash	397,884	32,735
Cash, cash equivalents, and restricted cash – beginning of period	1,100,243	1,073,353
Cash, cash equivalents, and restricted cash – end of period	1,498,127	1,106,088
Reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows above:
Cash and cash equivalents	1,492,910	1,096,174
Restricted cash, current included in prepaid expenses and other current assets	4,972	9,668
Restricted cash, noncurrent included in other assets, noncurrent	245	246
Total cash, cash equivalents, and restricted cash	$ 1,498,127	$ 1,106,088

Investments - Schedule of Contractual Maturities of Marketable Securities (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Less than one year	$ 2,774,308	$ 2,743,677
Due in one to five years	2,227,199	1,582,159
Total	$ 5,001,507	$ 4,325,836

Balance Sheet Components - Schedule of Accounts Receivable (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023	Oct. 31, 2022	Jan. 31, 2022
Balance Sheet Components [Abstract]
Accounts receivable, gross	$ 553,697	$ 590,610
Less: allowance for credit losses	(33,329)	(24,900)	$ (24,345)	$ (17,000)
Less: allowance for returns	(6,323)	(8,306)
Accounts receivable, net	$ 514,045	$ 557,404

Stockholders’ Equity and Equity Incentive Plans

9 Months Ended

Oct. 31, 2023

Stockholders' Equity Note [Abstract]

Stockholders’ Equity and Equity Incentive Plans

Common Stock

Our amended and restated certificate of incorporation authorizes the issuance of 2,000,000,000 shares of Class A common stock, $0.001 par value per share, and 300,000,000 shares of Class B common stock, $0.001 par value per share. Class A and Class B common stock are referred to as common stock throughout the notes to the condensed consolidated financial statements, unless otherwise noted.

Stock Repurchase Plan

In February 2022, our Board of Directors authorized a stock repurchase program of up to $1.0 billion of our Class A common stock, which was completed in December 2022. During the three and nine months ended October 31, 2022, we repurchased and subsequently retired 6,955,529 and 11,044,500 shares of our Class A common stock, respectively, for an aggregate amount of $564.8 million and $990.8 million, respectively.

Equity Incentive Plans

We have two equity incentive plans: the 2011 Global Share Plan (“2011 Plan”) and the 2019 Equity Incentive Plan (“2019 Plan”). All shares that remain available for future grants are under the 2019 Plan.

Stock Options

A summary of stock option activity under our equity incentive plan and related information is as follows:


	Stock Options
	Outstanding Stock Options	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value

	(in thousands, except share, life, and per share data)
Balance as of January 31, 2023	4,800,616	$	8.22	4.9	$	322,929
Exercised	(1,214,532)	$	6.86		$	75,266
Canceled/forfeited/expired	(22,230)	$	92.95
Outstanding and exercisable as of October 31, 2023	3,563,854	$	8.16	4.1	$	188,163

As of October 31, 2023, all options have vested and there is no unrecognized stock-based compensation expense remaining.

Restricted Stock Units

A summary of restricted stock unit (“RSU”) activity under our equity incentive plan and related information is as follows:


	RSUs
	RSUs	Weighted- Average Grant Date Fair Value Per Share
Unvested as of January 31, 2023	21,868,533	$	109.31
Granted	17,141,593	$	69.01

Vested	(8,747,679)	$	105.71
Canceled/forfeited	(3,772,653)	$	102.10
Unvested as of October 31, 2023	26,489,794	$	85.46

As of October 31, 2023, unrecognized stock-based compensation expense related to RSUs was $1,927.5 million, which is expected to be recognized over a weighted-average period of 2.6 years.

2019 Employee Stock Purchase Plan

In April 2019, we adopted the 2019 Employee Stock Purchase Plan (“ESPP”). As of October 31, 2023, unrecognized stock-based compensation expense related to the ESPP was $46.9 million, which is expected to be recognized over a weighted-average period of 1.2 years.

Stock-Based Compensation

The stock-based compensation expense by line item in the accompanying condensed consolidated statements of operations is summarized as follows:


	Three Months Ended October 31,				Nine Months Ended October 31,
	2023		2022		2023		2022

	(in thousands)
Cost of revenue	$	35,514	$	41,449	$	111,138	$	109,776
Research and development	86,662		83,202		250,165		208,654
Sales and marketing	86,593		125,144		293,104		329,100
General and administrative	50,165		53,020		148,381		120,163
Total stock-based compensation expense	$	258,934	$	302,815	$	802,788	$	767,693
Benefit from income taxes	(48,646)		(53,995)		(147,089)		(151,027)
Total stock-based compensation expense recorded to net income	$	210,288	$	248,820	$	655,699	$	616,666

Stockholders’ Equity and Equity Incentive Plans - Schedule of Stock-based Compensation Expense by Line Item (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	$ 258,934	$ 302,815	$ 802,788	$ 767,693
Benefit from income taxes	(48,646)	(53,995)	(147,089)	(151,027)
Total stock-based compensation expense recorded to net income	210,288	248,820	655,699	616,666
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	35,514	41,449	111,138	109,776
Research and development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	86,662	83,202	250,165	208,654
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	86,593	125,144	293,104	329,100
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation expense	$ 50,165	$ 53,020	$ 148,381	$ 120,163

Balance Sheet Components - Schedule of Other Noncurrent Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Balance Sheet Components [Abstract]
Accounts receivable, noncurrent	$ 31,025	$ 92,031
Intangible assets subject to amortization, net	50,335	31,420
Indefinite-lived intangible assets	25,239	25,239
Prepaid expenses, noncurrent	24,445	9,695
Other	12,248	19,489
Other assets, noncurrent	$ 143,292	$ 177,874

Restructuring Activities (Tables)

9 Months Ended

Oct. 31, 2023

Restructuring and Related Activities [Abstract]

Schedule of Restructuring Costs

The following table summarizes our restructuring expenses that were recorded as an operating expense in the condensed consolidated statement of operations for the nine months ended October 31, 2023:


	Nine Months Ended October 31, 2023
	(in thousands)
Cost of revenue	$	7,119
Research and development	19,629
Sales and marketing	32,930
General and administrative	13,315
Total restructuring expenses	$	72,993

Schedule of Restructuring Reserve by Type of Cost

The following table summarizes our restructuring liability that is included in accrued expenses and other current liabilities on the condensed consolidated balance sheet:


	Severance and termination benefits		Other
	(in thousands)
Balance as of January 31, 2023	$	—	$	—
Restructuring expenses	54,361		1,339
Cash payments	(54,361)		(1,339)
Balance as of October 31, 2023	$	—	$	—

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 141,212	$ 48,353	$ 338,630	$ 207,761
Other comprehensive income (loss):
Unrealized gain (loss) on available-for-sale marketable securities, net of income tax (expense) benefit of $(2,892) and $7,802 for the three months ended October 31, 2023 and 2022, respectively, and $(7,013) and $17,417 for the nine months ended October 31, 2023 and 2022, respectively	9,598	(24,555)	23,276	(54,814)
Comprehensive income	$ 150,810	$ 23,798	$ 361,906	$ 152,947

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481687/323-10-50-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482907/825-10-50-28

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482765/220-10-50-6

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-3

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-8

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-9

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-4

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480167/946-830-55-10

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483581/946-220-45-7

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(9))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(1)(d))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B

Reference 32: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-31

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483499/205-20-50-7

Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-28

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A

Reference 37: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B

Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

+ Details

Commitments and Contingencies (Details) $ in Millions							3 Months Ended		9 Months Ended
Commitments and Contingencies (Details) $ in Millions	Oct. 17, 2022 objector	May 19, 2022 objector	Oct. 21, 2021 USD ($)	Jul. 30, 2020 officer	Jun. 11, 2020 officer	Apr. 08, 2020 officer	Oct. 31, 2023 USD ($)	Jul. 31, 2023 USD ($)	Oct. 31, 2023 USD ($)	Jul. 17, 2023 USD ($)	Jan. 31, 2023 USD ($)	Nov. 17, 2021 lawsuit
Other Commitments [Line Items]
Purchase obligations with terms of greater than 12 months							$ 520.0		$ 520.0
Number of derivative lawsuits \| lawsuit												3
Pending Litigation \| Violation Of Securities Act Section 10(b), 20(a), and Rule 10b-5
Other Commitments [Line Items]
Amount of payment agreed upon										$ 150.0
Settled Litigation \| Violation Of Securities Act Section 10(b), 20(a), and Rule 10b-5
Other Commitments [Line Items]
Payments for legal settlements								$ 60.0
Payments for legal settlements, gross								150.0
Payments for legal settlements, net of insurance payment								$ 90.0
Loss contingency accrual											$ 7.5
Aggregate legal settlement charge							$ 0.0		$ 52.5
Violation Of Securities Act Section 10(b), 20(a), and Rule 10b-5
Other Commitments [Line Items]
Loss contingency, number of defendants \| officer				8	9	2
U.S. Privacy Class Actions
Other Commitments [Line Items]
Loss contingency, number of defendants \| objector	3	2
Payments for legal settlements			$ 85.0

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Current assets:
Cash and cash equivalents	$ 1,492,910	$ 1,086,830
Marketable securities	5,001,507	4,325,836
Accounts receivable, net of allowances of $39,652 and $33,206 as of October 31, 2023 and January 31, 2023, respectively	514,045	557,404
Deferred contract acquisition costs, current	205,169	223,250
Prepaid expenses and other current assets	271,128	163,092
Total current assets	7,484,759	6,356,412
Deferred contract acquisition costs, noncurrent	140,518	179,991
Property and equipment, net	291,844	252,821
Operating lease right-of-use assets	65,065	80,906
Strategic investments	353,022	398,992
Goodwill	307,295	122,641
Deferred tax assets	531,677	558,428
Other assets, noncurrent	143,292	177,874
Total assets	9,317,472	8,128,065
Current liabilities:
Accounts payable	14,431	14,414
Accrued expenses and other current liabilities	441,472	457,716
Deferred revenue, current	1,297,102	1,266,514
Total current liabilities	1,753,005	1,738,644
Deferred revenue, noncurrent	18,796	41,932
Operating lease liabilities, noncurrent	55,409	73,687
Other liabilities, noncurrent	76,861	67,195
Total liabilities	1,904,071	1,921,458
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.001 par value per share, 200,000,000 shares authorized as of October 31, 2023 and January 31, 2023; zero shares issued and outstanding as of October 31, 2023 and January 31, 2023	0	0
Common stock, $0.001 par value per share, 2,000,000,000 Class A shares authorized as of October 31, 2023 and January 31, 2023; 257,699,235 and 247,151,956 shares issued and outstanding as of October 31, 2023 and January 31, 2023, respectively; 300,000,000 Class B shares authorized as of October 31, 2023 and January 31, 2023; 46,638,730 and 46,670,894 shares issued and outstanding as of October 31, 2023 and January 31, 2023, respectively	305	294
Additional paid-in capital	4,949,757	4,104,880
Accumulated other comprehensive loss	(27,109)	(50,385)
Retained earnings	2,490,448	2,151,818
Total stockholders’ equity	7,413,401	6,206,607
Total liabilities and stockholders’ equity	$ 9,317,472	$ 8,128,065

Investments - Schedule of Marketable Securities (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Marketable Securities [Line Items]
Amortized Cost	$ 5,037,437	$ 4,392,058
Gross Unrealized Gains	64	599
Gross Unrealized Losses	(35,994)	(66,821)
Estimated Fair Value	5,001,507	4,325,836
Commercial paper
Marketable Securities [Line Items]
Amortized Cost	56,098	77,701
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	56,098	77,701
Agency bonds
Marketable Securities [Line Items]
Amortized Cost	1,608,658	823,027
Gross Unrealized Gains	4	63
Gross Unrealized Losses	(11,879)	(12,440)
Estimated Fair Value	1,596,783	810,650
Corporate and other debt securities
Marketable Securities [Line Items]
Amortized Cost	590,977	555,354
Gross Unrealized Gains	41	385
Gross Unrealized Losses	(4,231)	(4,845)
Estimated Fair Value	586,787	550,894
U.S. government agency securities
Marketable Securities [Line Items]
Amortized Cost	2,731,636	2,910,572
Gross Unrealized Gains	19	150
Gross Unrealized Losses	(19,879)	(49,507)
Estimated Fair Value	2,711,776	2,861,215
Treasury bills
Marketable Securities [Line Items]
Amortized Cost	50,068	25,404
Gross Unrealized Gains	0	1
Gross Unrealized Losses	(5)	(29)
Estimated Fair Value	$ 50,063	$ 25,376

Restructuring Activities - Additional Information (Details) - USD ($) $ in Thousands		3 Months Ended	9 Months Ended
	Feb. 07, 2023	Oct. 31, 2023	Oct. 31, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring costs		$ 0	$ 72,993
Employee Transition, Severance Payments, And Employee Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring costs			54,400
Employee Stock-Based Compensation Awards
Restructuring Cost and Reserve [Line Items]
Restructuring costs			17,300
Other Related Expenses
Restructuring Cost and Reserve [Line Items]
Restructuring costs			$ 1,300
The Plan
Restructuring Cost and Reserve [Line Items]
Reduction in current workforce	15.00%

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Net Income Per Share Attributable to Common Stockholders - Schedule of Computation of Basic and Diluted Net Income Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Numerator:
Net income	$ 141,212	$ 48,353	$ 338,630	$ 207,761
Net income attributable to common stockholders	$ 141,212	$ 48,353	$ 338,630	$ 207,744
Denominator:
Weighted-average shares used in computing net income per share attributable to common stockholders, basic (in shares)	302,493,182	295,537,026	299,037,999	297,765,848
Weighted-average shares used in computing net income per share attributable to common stockholders, diluted (in shares)	310,389,905	301,986,341	306,852,190	305,273,812
Net income per share attributable to common stockholders, basic (in dollars per share)	$ 0.47	$ 0.16	$ 1.13	$ 0.70
Net income per share attributable to common stockholders, diluted (in dollars per share)	$ 0.45	$ 0.16	$ 1.10	$ 0.68
Class A
Numerator:
Net income	$ 119,429	$ 40,726	$ 285,778	$ 174,835
Less: undistributed earnings attributable to participating securities	0	0	0	0
Net income attributable to common stockholders	119,429	40,726	285,778	174,835
Reallocation of net income attributable to common stockholders	(920)	(568)	(2,634)	(2,516)
Net income attributable to common stockholders, diluted	$ 118,509	$ 40,158	$ 283,144	$ 172,319
Denominator:
Weighted-average shares used in computing net income per share attributable to common stockholders, basic (in shares)	255,832,539	248,917,590	252,365,545	250,595,877
Weighted-average shares used in computing net income per share attributable to common stockholders, diluted (in shares)	260,488,614	250,803,759	256,573,508	253,217,436
Net income per share attributable to common stockholders, basic (in dollars per share)	$ 0.47	$ 0.16	$ 1.13	$ 0.70
Net income per share attributable to common stockholders, diluted (in dollars per share)	$ 0.45	$ 0.16	$ 1.10	$ 0.68
Class B
Numerator:
Net income	$ 21,783	$ 7,627	$ 52,852	$ 32,926
Less: undistributed earnings attributable to participating securities	0	0	0	(17)
Net income attributable to common stockholders	21,783	7,627	52,852	32,909
Reallocation of net income attributable to common stockholders	920	568	2,634	2,516
Net income attributable to common stockholders, diluted	$ 22,703	$ 8,195	$ 55,486	$ 35,425
Denominator:
Weighted-average shares used in computing net income per share attributable to common stockholders, basic (in shares)	46,660,643	46,619,436	46,672,454	47,169,971
Weighted-average shares used in computing net income per share attributable to common stockholders, diluted (in shares)	49,901,291	51,182,582	50,278,682	52,056,376
Net income per share attributable to common stockholders, basic (in dollars per share)	$ 0.47	$ 0.16	$ 1.13	$ 0.70
Net income per share attributable to common stockholders, diluted (in dollars per share)	$ 0.45	$ 0.16	$ 1.10	$ 0.68

Balance Sheet Components - Schedule of Other Liabilities Non Current (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Balance Sheet Components [Abstract]
Sales and other non-income tax liabilities	$ 44,412	$ 42,321
Other	32,449	24,874
Other liabilities, noncurrent	$ 76,861	$ 67,195

Summary of Business and Significant Accounting Policies	9 Months Ended
Summary of Business and Significant Accounting Policies	Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of Business and Significant Accounting Policies	Summary of Business and Significant Accounting Policies Description of Business Zoom Video Communications, Inc. and its subsidiaries (collectively, “Zoom,” the “Company,” “we,” “us,” or “our”) connect people through our core unified communications and collaboration platform, which frictionlessly brings together video, phone, chat, webinars events, and contact center, and enables meaningful experiences across disparate devices and locations. We were incorporated in the state of Delaware in April 2011, and are headquartered in San Jose, California. Fiscal Year Our fiscal year ends on January 31. References to fiscal year 2024, for example, refer to the fiscal year ending January 31, 2024. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) and applicable regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting, and include the accounts of Zoom Video Communications, Inc., its subsidiaries, and variable interest entities for which we are the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated balance sheet as of January 31, 2023 included herein was derived from the audited financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. The unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets, statements of operations, statements of comprehensive income, statements of stockholders’ equity, and statements of cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended January 31, 2023, filed with the SEC on March 3, 2023. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the estimated expected benefit period for deferred contract acquisition costs, stock-based compensation expense, the fair value of marketable securities, acquired intangible assets and goodwill, the valuation of deferred income tax assets and uncertain tax positions, and accruals and contingencies. Actual results could materially differ from those estimates. Summary of Significant Accounting Policies Our significant accounting policies are discussed in Note 1. “Summary of Business and Significant Accounting Policies” in the notes to consolidated financial statements included in our Annual Report on Form 10-K for the year ended January 31, 2023, filed with the SEC on March 3, 2023. There have been no significant changes to these policies during the nine months ended October 31, 2023.

Stockholders’ Equity and Equity Incentive Plans - Additional Information (Details)	3 Months Ended	9 Months Ended
	Oct. 31, 2022 USD ($) shares	Oct. 31, 2023 USD ($) plan $ / shares shares	Oct. 31, 2022 USD ($) shares	Jan. 31, 2023 $ / shares shares	Feb. 28, 2022 USD ($)
Class of Stock [Line Items]
Common stock, par value (in dollars per share) \| $ / shares		$ 0.001		$ 0.001
Stock repurchase plan, authorized amount (up to) \| $					$ 1,000,000,000
Number of equity incentive plans \| plan		2
Unrecognized stock-based compensation expenses related to outstanding unvested stock options (in shares) \| $		$ 0
RSUs
Class of Stock [Line Items]
Unrecognized stock-based compensation expenses \| $		$ 1,927,500,000
Unrecognized stock-based compensation excepted to be recognized over a weighted-average period (in years)		2 years 7 months 6 days
Employee Stock Purchase Plan
Class of Stock [Line Items]
Unrecognized stock-based compensation expenses \| $		$ 46,900,000
Unrecognized stock-based compensation excepted to be recognized over a weighted-average period (in years)		1 year 2 months 12 days
Class A Common Stock
Class of Stock [Line Items]
Common stock, authorized (in shares) \| shares		2,000,000,000		2,000,000,000
Stock repurchased and retired during period (in shares) \| shares	6,955,529		11,044,500
Stock repurchased and retired during period \| $	$ 564,800,000		$ 990,800,000
Class A Common Stock \| Initial Public Offering
Class of Stock [Line Items]
Common stock, authorized (in shares) \| shares		2,000,000,000
Common stock, par value (in dollars per share) \| $ / shares		$ 0.001
Class B Common Stock
Class of Stock [Line Items]
Common stock, authorized (in shares) \| shares		300,000,000		300,000,000
Class B Common Stock \| Initial Public Offering
Class of Stock [Line Items]
Common stock, authorized (in shares) \| shares		300,000,000
Common stock, par value (in dollars per share) \| $ / shares		$ 0.001

Fair Value Measurements

9 Months Ended

Oct. 31, 2023

Fair Value Disclosures [Abstract]

Fair Value Measurements

The following tables present information about our financial instruments that are measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation inputs utilized to determine such fair value:


	As of October 31, 2023
	Fair Value		Level 1		Level 2		Level 3

	(in thousands)
Financial Assets:
Money market funds	$	865,017	$	865,017	$	—	$	—
Treasury bills	164,958		—		164,958		—


Cash equivalents	1,029,975		865,017		164,958		—
Commercial paper	56,098		—		56,098		—
Agency bonds	1,596,783		—		1,596,783		—
Corporate and other debt securities	586,787		—		586,787		—
U.S. government agency securities	2,711,776		—		2,711,776		—
Treasury bills	50,063		—		50,063		—
Marketable securities	5,001,507		—		5,001,507		—


Certificates of deposit included in other assets, noncurrent	245		—		245		—
Publicly held equity securities included in strategic investments	65,724		65,724		—		—
Privately held debt securities included in strategic investments	3,791		—		—		3,791
Total financial assets	$	6,101,242	$	930,741	$	5,166,710	$	3,791


	As of January 31, 2023
	Fair Value		Level 1		Level 2		Level 3

	(in thousands)
Financial Assets:
Money market funds	$	310,571	$	310,571	$	—	$	—



Cash equivalents	310,571		310,571		—		—
Commercial paper	77,701		—		77,701		—
Agency bonds	810,650		—		810,650		—
Corporate and other debt securities	550,894		—		550,894		—
U.S. government agency securities	2,861,215		—		2,861,215		—
Treasury bills	25,376		—		25,376		—
Marketable securities	4,325,836		—		4,325,836		—


Certificates of deposit included in other assets, noncurrent	272		—		272		—
Publicly held equity securities included in strategic investments	171,975		171,975		—		—
Privately held debt securities included in strategic investments	14,400		—		—		14,400
Total financial assets	$	4,823,054	$	482,546	$	4,326,108	$	14,400

We classify our highly liquid money market funds and publicly held equity securities within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. We classify our commercial paper, agency bonds, corporate and other debt securities, U.S. government agency securities, treasury bills, and certificates of deposit within Level 2 because they are valued using inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security, which may not be actively traded. We classify our privately held debt securities as Level 3 due to the lack of relevant observable market data over fair value inputs, such as the probability weighting of the various scenarios that can impact settlement of the arrangement.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Net Income Per Share Attributable to Common Stockholders (Tables)

9 Months Ended

Oct. 31, 2023

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Net Income Per Share

The following table sets forth the computation of basic and diluted net income per share attributable to common stockholders for the periods presented:


	Three Months Ended October 31,								Nine Months Ended October 31,
	2023				2022				2023				2022
	Class A		Class B		Class A		Class B		Class A		Class B		Class A		Class B
	(in thousands, except share and per share data)
Numerator:
Net income	$	119,429	$	21,783	$	40,726	$	7,627	$	285,778	$	52,852	$	174,835	$	32,926
Less: undistributed earnings attributable to participating securities	—		—		—		—		—		—		—		(17)
Net income attributable to common stockholders, basic	$	119,429	$	21,783	$	40,726	$	7,627	$	285,778	$	52,852	$	174,835	$	32,909
Reallocation of net income attributable to common stockholders	(920)		920		(568)		568		(2,634)		2,634		(2,516)		2,516
Net income attributable to common stockholders, diluted	$	118,509	$	22,703	$	40,158	$	8,195	$	283,144	$	55,486	$	172,319	$	35,425
Denominator:
Weighted-average shares used in computing net income per share attributable to common stockholders, basic	255,832,539		46,660,643		248,917,590		46,619,436		252,365,545		46,672,454		250,595,877		47,169,971
Weighted-average shares used in computing net income per share attributable to common stockholders, diluted	260,488,614		49,901,291		250,803,759		51,182,582		256,573,508		50,278,682		253,217,436		52,056,376
Net income per share attributable to common stockholders, basic	$	0.47	$	0.47	$	0.16	$	0.16	$	1.13	$	1.13	$	0.70	$	0.70
Net income per share attributable to common stockholders, diluted	$	0.45	$	0.45	$	0.16	$	0.16	$	1.10	$	1.10	$	0.68	$	0.68

Schedule of Potential Shares of Common Stock Excluded from Computation of Diluted Net Income Per Share Attributable to Common Stockholders

The potential shares of common stock that were excluded from the computation of diluted net income per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive, are as follows:


	Three Months Ended October 31,				Nine Months Ended October 31,
	2023		2022		2023		2022
	Class A	Class B	Class A	Class B	Class A	Class B	Class A	Class B
Unvested RSUs	7,869,069	—	12,741,748	—	9,345,635	—	7,656,321	—
Purchase rights committed under the ESPP	1,573,013	—	2,395,761	—	1,996,477	—	1,462,148	—
Outstanding stock options	102,711	—	124,547	—	111,803	—	75,984	—
Total	9,544,793	—	15,262,056	—	11,453,915	—	9,194,453	—

Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Balance Sheet Components [Abstract]
Prepaid expenses	$ 233,494	$ 123,493
Other receivables	23,531	17,142
Restricted cash from international employee stock sales	4,972	13,141
Other	9,131	9,316
Prepaid expenses and other current assets	$ 271,128	$ 163,092

Income Taxes

9 Months Ended

Oct. 31, 2023

Income Tax Disclosure [Abstract]

Income Taxes

We compute our provision for income taxes by applying the estimated annual effective tax rate to year-to-date ordinary income and adjust the provision for discrete tax items recorded in the period. In each quarter, we update the estimated annual effective tax rate and make a year-to-date adjustment to the provision.

The following table provides details of the provision for income taxes:


	Three Months Ended October 31,						Nine Months Ended October 31,
	2023			2022			2023			2022

	(in thousands, except percentages)
Income before provision for income taxes	$	185,826		$	54,749		$	479,429		$	288,820
Provision for income taxes	44,614			6,396			140,799			81,059
Effective tax rate	24.0		%	11.7		%	29.4		%	28.1		%

The year-over-year change in effective tax rate for the three and nine months ended October 31, 2023 was due primarily to changes in the valuation allowance, tax shortfalls and windfalls on stock-based compensation, and the foreign-derived intangible income deduction. For both the three and nine months ended October 31, 2023 and October 31, 2022, the effective tax rate differed from the U.S. federal statutory rate due primarily to the foreign-derived intangible income deduction and research credits, offset by tax shortfalls on stock-based compensation, the valuation allowance recorded on certain deferred tax assets, and other compensation-related permanent differences.

As required by the 2017 Tax Cuts and Jobs Act, we started capitalizing research and development expenses incurred beginning in fiscal year 2023. These expenses are capitalized and amortized over five years for domestic research and fifteen years for international research. The mandatory capitalization requirement increases our cash tax liabilities but also decreases our effective tax rate due to increasing the foreign-derived intangible income deduction. The cash flow impact will decrease over time as capitalized research and development expenditures continue to amortize.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//740/tableOfContent

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482685/740-10-50-14

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482685/740-10-50-21

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482526/740-270-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482685/740-10-50-17

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482603/740-30-50-2

+ Details

Revenue Recognition - Summary Disaggregation of Revenue by Region (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 1,136,727	$ 1,101,899	$ 3,380,767	$ 3,275,157
Revenue from Contract with Customer Benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as a percent)	100.00%	100.00%	100.00%	100.00%
Americas
Disaggregation of Revenue [Line Items]
Revenue	$ 814,311	$ 773,576	$ 2,407,333	$ 2,264,647
Americas \| Revenue from Contract with Customer Benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as a percent)	71.60%	70.20%	71.20%	69.10%
Asia Pacific (“APAC”)
Disaggregation of Revenue [Line Items]
Revenue	$ 143,917	$ 146,196	$ 429,703	$ 444,372
Asia Pacific (“APAC”) \| Revenue from Contract with Customer Benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as a percent)	12.70%	13.30%	12.70%	13.60%
Europe, Middle East, and Africa (“EMEA”)
Disaggregation of Revenue [Line Items]
Revenue	$ 178,499	$ 182,127	$ 543,731	$ 566,138
Europe, Middle East, and Africa (“EMEA”) \| Revenue from Contract with Customer Benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as a percent)	15.70%	16.50%	16.10%	17.30%

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 924
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-42

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-40

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-41

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-4

+ Details

Stockholders’ Equity and Equity Incentive Plans (Tables)

9 Months Ended

Oct. 31, 2023

Stockholders' Equity Note [Abstract]

Schedule of Stock Option Activity Under Equity Incentive Plan

A summary of stock option activity under our equity incentive plan and related information is as follows:


	Stock Options
	Outstanding Stock Options	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value

	(in thousands, except share, life, and per share data)
Balance as of January 31, 2023	4,800,616	$	8.22	4.9	$	322,929
Exercised	(1,214,532)	$	6.86		$	75,266
Canceled/forfeited/expired	(22,230)	$	92.95
Outstanding and exercisable as of October 31, 2023	3,563,854	$	8.16	4.1	$	188,163

Schedule of Restricted Stock Units (RSUs) Activity Under Equity Incentive Plan

A summary of restricted stock unit (“RSU”) activity under our equity incentive plan and related information is as follows:


	RSUs
	RSUs	Weighted- Average Grant Date Fair Value Per Share
Unvested as of January 31, 2023	21,868,533	$	109.31
Granted	17,141,593	$	69.01

Vested	(8,747,679)	$	105.71
Canceled/forfeited	(3,772,653)	$	102.10
Unvested as of October 31, 2023	26,489,794	$	85.46

Schedule of Stock-based Compensation Expense by Line Item

The stock-based compensation expense by line item in the accompanying condensed consolidated statements of operations is summarized as follows:


	Three Months Ended October 31,				Nine Months Ended October 31,
	2023		2022		2023		2022

	(in thousands)
Cost of revenue	$	35,514	$	41,449	$	111,138	$	109,776
Research and development	86,662		83,202		250,165		208,654
Sales and marketing	86,593		125,144		293,104		329,100
General and administrative	50,165		53,020		148,381		120,163
Total stock-based compensation expense	$	258,934	$	302,815	$	802,788	$	767,693
Benefit from income taxes	(48,646)		(53,995)		(147,089)		(151,027)
Total stock-based compensation expense recorded to net income	$	210,288	$	248,820	$	655,699	$	616,666

Revenue Recognition - Remaining Performance Obligation (Details) $ in Millions	Oct. 31, 2023 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation	$ 3,571.7
Billed Consideration
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation	1,315.9
Unbilled Consideration
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation	$ 2,255.8
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation (as a percent)	58.00%
Revenue remaining performance obligation, expected timing of satisfaction period (in months)	12 months

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Current assets:
Accounts receivable, allowances	$ 39,652	$ 33,206
Stockholders’ equity:
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, authorized (in shares)	200,000,000	200,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Class A Common Stock
Stockholders’ equity:
Common stock, authorized (in shares)	2,000,000,000	2,000,000,000
Common stock, issued (in shares)	257,699,235	247,151,956
Common stock, outstanding (in shares)	257,699,235	247,151,956
Class B Common Stock
Stockholders’ equity:
Common stock, authorized (in shares)	300,000,000	300,000,000
Common stock, issued (in shares)	46,638,730	46,670,894
Common stock, outstanding (in shares)	46,638,730	46,670,894

Fair Value Measurements (Tables)

9 Months Ended

Oct. 31, 2023

Fair Value Disclosures [Abstract]

Schedule of Financial Instruments Measured at Fair Value on Recurring Basis


	As of October 31, 2023
	Fair Value		Level 1		Level 2		Level 3

	(in thousands)
Financial Assets:
Money market funds	$	865,017	$	865,017	$	—	$	—
Treasury bills	164,958		—		164,958		—


Cash equivalents	1,029,975		865,017		164,958		—
Commercial paper	56,098		—		56,098		—
Agency bonds	1,596,783		—		1,596,783		—
Corporate and other debt securities	586,787		—		586,787		—
U.S. government agency securities	2,711,776		—		2,711,776		—
Treasury bills	50,063		—		50,063		—
Marketable securities	5,001,507		—		5,001,507		—


Certificates of deposit included in other assets, noncurrent	245		—		245		—
Publicly held equity securities included in strategic investments	65,724		65,724		—		—
Privately held debt securities included in strategic investments	3,791		—		—		3,791
Total financial assets	$	6,101,242	$	930,741	$	5,166,710	$	3,791


	As of January 31, 2023
	Fair Value		Level 1		Level 2		Level 3

	(in thousands)
Financial Assets:
Money market funds	$	310,571	$	310,571	$	—	$	—



Cash equivalents	310,571		310,571		—		—
Commercial paper	77,701		—		77,701		—
Agency bonds	810,650		—		810,650		—
Corporate and other debt securities	550,894		—		550,894		—
U.S. government agency securities	2,861,215		—		2,861,215		—
Treasury bills	25,376		—		25,376		—
Marketable securities	4,325,836		—		4,325,836		—


Certificates of deposit included in other assets, noncurrent	272		—		272		—
Publicly held equity securities included in strategic investments	171,975		171,975		—		—
Privately held debt securities included in strategic investments	14,400		—		—		14,400
Total financial assets	$	4,823,054	$	482,546	$	4,326,108	$	14,400

Investments - Additional Information (Details) - USD ($)	3 Months Ended			9 Months Ended
	Oct. 31, 2023	Jul. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022	Jan. 31, 2023
Net Investment Income [Line Items]
Unrealized losses for securities in unrealized loss position for less than 12 months	$ 22,100,000			$ 22,100,000		$ 24,800,000
Unrealized losses for securities in unrealized loss position for 12 months or longer	13,900,000			13,900,000		$ 42,000,000
Available-for-sale, realized gain (loss)	$ 0		$ 0	0	$ 0
Purchase of strategic investments				52,800,000	65,050,000
Proceeds from strategic investments				107,244,000	$ 300,000
Investment in Equity Securities of Private Companies
Net Investment Income [Line Items]
Purchase of strategic investments				$ 52,800,000
Investment in Equity Securities of Public Companies
Net Investment Income [Line Items]
Proceeds from strategic investments		$ 107,200,000

Insider Trading Arrangements

3 Months Ended

9 Months Ended

Oct. 31, 2023

Trading Arrangements, by Individual

Material Terms of Trading Arrangement

Trading Arrangements

During the Company’s last fiscal quarter, the Company’s directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions or written plans for the purchase or sale of the Company’s securities set forth in the table below.

Type of Trading Arrangement

Name and Position

Action

Adoption/ Termination

Date

Rule 10b5-1*

Non-

Rule 10b5-1**

Total Shares of Class A Common Stock to be Sold***

Expiration Date

Shane Crehan, Chief Accounting Officer

Adoption

10/12/2023

35,412

10/30/2024

* Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.

** “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act.

*** Represents the maximum number of shares that may be sold pursuant to the 10b5-1 arrangement. The actual number of shares sold will be dependent on the satisfaction of certain conditions as set forth in the written plan.

Non-Rule 10b5-1 Arrangement Adopted

false

Rule 10b5-1 Arrangement Terminated

false

Non-Rule 10b5-1 Arrangement Terminated

false

Shane Crehan [Member]

Trading Arrangements, by Individual

Name

Shane Crehan

Title

Chief Accounting Officer

Rule 10b5-1 Arrangement Adopted

true

Adoption Date

10/12/2023

Arrangement Duration

384 days

Aggregate Available

35,412

Balance Sheet Components - Schedule of Property and Equipment Net (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 508,709	$ 412,503
Less: accumulated depreciation and amortization	(216,865)	(159,682)
Property and equipment, net	291,844	252,821
Servers
Property, Plant and Equipment [Line Items]
Property and equipment, gross	333,665	249,776
Software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	92,055	84,082
Computer and office equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	43,869	48,325
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	35,785	25,948
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 3,335	$ 4,372

Balance Sheet Components (Tables)

9 Months Ended

Oct. 31, 2023

Balance Sheet Components [Abstract]

Schedule of Accounts Receivable

Our short-term accounts receivable consist of the following:


	As of
	October 31, 2023		January 31, 2023

	(in thousands)
Accounts receivable, gross	$	553,697	$	590,610
Less: allowance for credit losses	(33,329)		(24,900)
Less: allowance for returns	(6,323)		(8,306)
Accounts receivable, net	$	514,045	$	557,404

Schedule of Allowance for Credit Loss

Below is a rollforward of our allowance for credit losses for the nine months ended October 31, 2023 and 2022:




	2023		2022
	(in thousands)
Balance as of January 31	$	24,900	$	17,000
Provision for credit losses	39,397		34,610
Write-offs	(30,968)		(27,265)
Balance as of October 31	$	33,329	$	24,345

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following:


	As of
	October 31, 2023		January 31, 2023

	(in thousands)
Prepaid expenses	$	233,494	$	123,493
Other receivables	23,531		17,142
Restricted cash from international employee stock sales	4,972		13,141
Other	9,131		9,316
Prepaid expenses and other current assets	$	271,128	$	163,092

Schedule of Property and Equipment

Property and equipment consisted of the following:


	As of
	October 31, 2023		January 31, 2023

	(in thousands)
Servers	$	333,665	$	249,776
Software	92,055		84,082
Computer and office equipment	43,869		48,325
Leasehold improvements	35,785		25,948
Furniture and fixtures	3,335		4,372
Property and equipment, gross	508,709		412,503
Less: accumulated depreciation and amortization	(216,865)		(159,682)
Property and equipment, net	$	291,844	$	252,821

Schedule of Other Assets, Noncurrent

Other assets, noncurrent consisted of the following:


	As of
	October 31, 2023		January 31, 2023

	(in thousands)
Accounts receivable, noncurrent	$	31,025	$	92,031

Intangible assets subject to amortization, net	50,335		31,420
Indefinite-lived intangible assets	25,239		25,239
Prepaid expenses, noncurrent	24,445		9,695


Other	12,248		19,489
Other assets, noncurrent	$	143,292	$	177,874

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following:


	As of
	October 31, 2023		January 31, 2023

	(in thousands)

Accrued expenses	$	154,121	$	160,189
Accrued compensation and benefits	163,768		139,105
Income tax liabilities	17,333		46,441
Sales and other non-income tax liabilities	28,226		33,859
Customer deposit liabilities	40,733		33,640
Operating lease liabilities, current	23,904		22,790


Other	13,387		21,692
Accrued expenses and other current liabilities	$	441,472	$	457,716

Schedule of Other Liabilities, Noncurrent

Other liabilities, noncurrent consisted of the following:


	As of
	October 31, 2023		January 31, 2023

	(in thousands)
Sales and other non-income tax liabilities	$	44,412	$	42,321



Other	32,449		24,874
Other liabilities, noncurrent	$	76,861	$	67,195

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Oct. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Non-cancelable Purchase Obligations As of October 31, 2023, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer of approximately $520.0 million in addition to the corresponding amount disclosed in our Annual Report on Form 10-K for the year ended January 31, 2023 filed with the SEC on March 3, 2023, mainly related to third-party cloud hosting. Other Contingencies In June 2020, we received a grand jury subpoena from the Department of Justice’s U.S. Attorney’s Office for Eastern District of New York (“EDNY”), which requested information regarding our interactions with foreign governments and foreign political parties, including the Chinese government, as well as information regarding storage of and access to user data, the development and implementation of Zoom’s privacy policies, and the actions we took responding to law enforcement requests from the Chinese government. In July 2020, we received subpoenas from the Department of Justice’s U.S. Attorney’s Office for the Northern District of California (“NDCA”) and the SEC. Both subpoenas seek documents and information relating to various security, data protection and privacy matters, including our encryption, and our statements relating thereto, as well as calculation of usage metrics and related public statements. In addition, the NDCA subpoena seeks information relating to any contacts between our employees and representatives of the Chinese government, and any attempted or successful influence by any foreign government in our policies, procedures, practices, and actions as they relate to users in the United States. We have since received additional subpoenas from EDNY and NDCA seeking related information. We are fully cooperating with all of these investigations and have been conducting our own thorough internal investigation. These investigations are ongoing, and we do not know when they will be completed, which facts we will ultimately discover as a result of the investigations, or what actions the government may or may not take. We cannot predict the outcome of these investigations, and a negative outcome in any or all of these matters could cause us to incur substantial fines, penalties, or other financial exposure, as well as reputational harm. Legal Proceedings On June 11, 2020 and July 30, 2020, purported shareholder derivative complaints were filed in the United States District Court for the District of Delaware. The first complaint names as defendants nine of our officers and directors, and the second complaint names eight of our officers and directors. The lawsuits assert state and federal claims and are based on the same alleged misstatements as the shareholder class action complaint. The lawsuits accuse our board of directors of failing to exercise reasonable and prudent supervision over our management, policies, practices, and internal controls. The plaintiffs seek unspecified monetary damages on behalf of us as well as governance reforms. On September 25, 2020, the derivative cases were consolidated. On October 27, 2021, a third substantially identical lawsuit was filed in the same court against the same defendants, seeking unspecified monetary damages and governance reforms. On November 17, 2021, all three derivative lawsuits were consolidated. The consolidated case was stayed pending resolution of the motion to dismiss the securities class action. On April 11, 2023, the court entered a stipulated order that requires defendants to answer, move, or otherwise respond to the operative complaint by June 12, 2023. On June 12, 2023, defendants filed a motion to dismiss the consolidated case. On August 11, 2023, the plaintiff in the consolidated case filed an amended complaint. On October 18, 2023, defendants filed their motion to dismiss the amended complaint. We are vigorously defending ourselves against these lawsuits. Given the uncertainty of litigation, the preliminary stage of the cases, and the legal standards that must be met for, among other things, class certification and success on the merits, we cannot estimate the reasonably possible loss or range of loss that may result from these actions. Beginning on March 30, 2020, multiple putative class actions were filed against us in various U.S. federal district courts and state courts relating to our alleged privacy and security practices, including alleged data sharing with third parties (the “U.S. Privacy Class Actions”). The plaintiffs claim violations of a variety of state consumer protection and privacy laws, and also assert state constitutional and common law claims, such as negligence and unjust enrichment. The U.S. Privacy Class Actions seek to certify both nationwide and state-specific classes of individuals using our services in certain time periods. The plaintiffs seek various forms of injunctive and monetary relief, including restitution, statutory and actual damages, punitive damages, and attorneys’ fees. The federal cases have been transferred to and consolidated in the NDCA with our consent; lead plaintiffs’ counsel have been appointed; and plaintiffs filed their first amended consolidated class action complaint on October 28, 2020. On March 11, 2021, the court granted in part, and denied in part, our motion to dismiss, and gave plaintiffs leave to amend. On July 30, 2021, we entered into a settlement agreement with plaintiffs to settle the action on a classwide basis, and plaintiffs filed a motion for preliminary approval of the settlement with the court on July 31, 2021. On October 21, 2021, the Court preliminarily approved the settlement. Under the terms of the settlement, we have paid $85.0 million into an escrow account that will be used to pay claims filed by settlement class members, attorneys’ fees and expenses, administrative costs, and service payments to plaintiffs. On April 21, 2022, the Court granted final approval of the settlement. On May 19, 2022, two objectors to the settlement appealed the Court's final approval order. On May 20, 2022, a third objector appealed the Court’s final approval order. On October 17, 2022, we, plaintiffs, and all three objector-appellants agreed to settle the appeals, and on October 27, 2022, we and plaintiffs initiated proceedings in the district court to obtain Court approval of the settlements, which the district court approved on December 16, 2022. On January 13, 2023, a new objector appealed the court’s December 16, 2022 approval of the settlements of the prior appeals, and on March 31, 2023, the Ninth Circuit dismissed the new appeal. With the appeals resolved, the class action settlement is final and the settlement administrator is in the process of making payments to claimants. On April 7, 2020 and April 8, 2020, securities class action complaints were filed against us and two of our officers in the United States District Court for the NDCA. The plaintiffs are purported stockholders of ours. The complaints allege, among other things, that we violated Sections 10(b) and 20(a) of the Exchange Act, and Rule 10b-5 by making false and misleading statements and omissions of material fact about our data privacy and security measures. The complaints seek unspecified damages, interest, fees, and costs. On May 18, 2020, the actions were consolidated. On November 4, 2020, the court appointed a lead plaintiff. On December 23, 2020, the lead plaintiff filed a consolidated complaint. We filed a motion to dismiss the consolidated complaint on May 20, 2021. Plaintiff filed an opposition to our motion to dismiss on July 9, 2021. Our reply in support of the motion to dismiss was filed on August 9, 2021. On February 16, 2022, the court granted in part, and denied in part, our motion to dismiss. On March 14, 2022, we moved for reconsideration of the court’s ruling on the motion to dismiss. On March 22, 2022, the court ordered plaintiff to respond to our motion, which plaintiff did on March 29, 2022. On April 22, 2022, we answered the complaint. On March 8, 2023, the court denied our motion for reconsideration. On April 6, 2023, the court entered a scheduling order. On July 17, 2023, the parties entered into a stipulation and agreement of settlement (the “Stipulation”) to resolve this matter. Under the terms of the stipulation, in exchange for the release and dismissal with prejudice of all claims against all defendants in the matter, we have agreed to pay and/or cause our insurance carriers to pay a total of $150.0 million. The Stipulation and settlement remain subject to preliminary and final approval by the court. On July 25, 2023, the court entered an order staying further proceedings in the matter pending the filing of a motion for preliminary approval of the settlement. On October 17, 2023, lead plaintiff filed a motion for preliminary approval of the settlement. A hearing on the motion for preliminary approval of the settlement has been scheduled for December 7, 2023. As a result of the settlement, we made net payments of $60.0 million ($150.0 million for the settlement net of $90.0 million covered by insurance) during the three months ended July 31, 2023, of which $7.5 million had been accrued during the year ended January 31, 2023 and $52.5 million was recorded as a general and administrative expense in our condensed consolidated statement of operations for the nine months ended October 31, 2023. No additional legal settlement charges were recorded for the three months ended October 31, 2023.In addition, from time to time, we are involved in various other legal proceedings arising from the normal course of business activities. We are not presently a party to any other such litigation the outcome of which, we believe, if determined adversely to us, would individually, or taken together, have a material adverse effect on our business, operating results, cash flows, or financial condition. Defending such proceedings is costly and can impose a significant burden on management and employees. We may receive unfavorable preliminary or interim rulings in the course of litigation, and there can be no assurances that favorable final outcomes will be obtained.

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Pay vs Performance Disclosure
Net income	$ 141,212	$ 48,353	$ 338,630	$ 207,761

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

Balance Sheet Components - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Balance Sheet Components [Abstract]
Depreciation and amortization expense	$ 23.5	$ 19.9	$ 68.1	$ 54.6

Revenue Recognition

9 Months Ended

Oct. 31, 2023

Revenue from Contract with Customer [Abstract]

Revenue Recognition

Disaggregation of Revenue

The following table summarizes revenue by region based on the billing address of customers:


	Three Months Ended October 31,								Nine Months Ended October 31,
	2023				2022				2023				2022
	Amount		Percentage of Revenue		Amount		Percentage of Revenue		Amount		Percentage of Revenue		Amount		Percentage of Revenue

	(in thousands, except percentages)
Americas	$	814,311	71.6	%	$	773,576	70.2	%	$	2,407,333	71.2	%	$	2,264,647	69.1	%
Asia Pacific (“APAC”)	143,917		12.7		146,196		13.3		429,703		12.7		444,372		13.6
Europe, Middle East, and Africa (“EMEA”)	178,499		15.7		182,127		16.5		543,731		16.1		566,138		17.3
Total	$	1,136,727	100.0	%	$	1,101,899	100.0	%	$	3,380,767	100.0	%	$	3,275,157	100.0	%

Contract Balances

We receive payments from customers based on a billing schedule as established in our customer contracts. Accounts receivable are recorded when we contractually have the right to consideration. In some arrangements, a right to consideration for our performance under the customer contract may occur before invoicing to the customer, resulting in an unbilled accounts receivable. The amount of unbilled accounts receivable included within accounts receivable, net was $132.3 million and $91.6 million as of October 31, 2023 and January 31, 2023, respectively, and the amount of unbilled accounts receivable included within other assets, noncurrent was immaterial as of October 31, 2023 and January 31, 2023.

Contract liabilities consist of deferred revenue. Revenue is deferred when we have the right to invoice in advance of performance under a customer contract. The current portion of deferred revenue balances is recognized over the next 12 months. The amount of revenue recognized during the three months ended October 31, 2023 and 2022 that was included in deferred revenue at the beginning of each period was $600.8 million and $586.1 million, respectively, and $1,159.6 million and $1,058.7 million during the nine months ended October 31, 2023 and 2022, respectively.

Remaining Performance Obligations

The terms of our subscription agreements are monthly, annual, and multiyear, and we may bill for the full term in advance or on an annual, quarterly, or monthly basis, depending on the billing terms with customers. As of October 31, 2023, the aggregate amount of the transaction price allocated to our remaining performance obligations was $3,571.7 million, which consists of both billed consideration in the amount of $1,315.9 million and unbilled consideration in the amount of $2,255.8 million that we expect to recognize as revenue. We expect to recognize 58% of our remaining performance obligations as revenue over the next 12 months and the remainder thereafter.

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-9

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-10

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-15

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-13

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 606
-Publisher FASB
-URI https://asc.fasb.org//606/tableOfContent

+ Details

Fair Value Measurements (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Financial Assets:
Marketable securities	$ 5,001,507	$ 4,325,836
Commercial paper
Financial Assets:
Marketable securities	56,098	77,701
Agency bonds
Financial Assets:
Marketable securities	1,596,783	810,650
Corporate and other debt securities
Financial Assets:
Marketable securities	586,787	550,894
U.S. government agency securities
Financial Assets:
Marketable securities	2,711,776	2,861,215
Fair Value, Recurring Basis
Financial Assets:
Cash equivalents	1,029,975	310,571
Marketable securities	5,001,507	4,325,836
Publicly held equity securities included in strategic investments	65,724	171,975
Total financial assets	6,101,242	4,823,054
Fair Value, Recurring Basis \| Commercial paper
Financial Assets:
Marketable securities	56,098	77,701
Fair Value, Recurring Basis \| Agency bonds
Financial Assets:
Marketable securities	1,596,783	810,650
Fair Value, Recurring Basis \| Corporate and other debt securities
Financial Assets:
Marketable securities	586,787	550,894
Fair Value, Recurring Basis \| U.S. government agency securities
Financial Assets:
Marketable securities	2,711,776	2,861,215
Fair Value, Recurring Basis \| Treasury bills
Financial Assets:
Marketable securities	50,063	25,376
Fair Value, Recurring Basis \| Certificates of deposit included in other assets, noncurrent
Financial Assets:
Certificates of deposit included in other assets, noncurrent	245	272
Fair Value, Recurring Basis \| Privately held debt securities included in strategic investments
Financial Assets:
Marketable securities	3,791	14,400
Fair Value, Recurring Basis \| Money market funds
Financial Assets:
Cash equivalents	865,017	310,571
Fair Value, Recurring Basis \| Treasury bills
Financial Assets:
Cash equivalents	164,958
Fair Value, Recurring Basis \| Level 1
Financial Assets:
Cash equivalents	865,017	310,571
Marketable securities	0	0
Publicly held equity securities included in strategic investments	65,724	171,975
Total financial assets	930,741	482,546
Fair Value, Recurring Basis \| Level 1 \| Commercial paper
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 1 \| Agency bonds
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 1 \| Corporate and other debt securities
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 1 \| U.S. government agency securities
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 1 \| Treasury bills
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 1 \| Certificates of deposit included in other assets, noncurrent
Financial Assets:
Certificates of deposit included in other assets, noncurrent	0	0
Fair Value, Recurring Basis \| Level 1 \| Privately held debt securities included in strategic investments
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 1 \| Money market funds
Financial Assets:
Cash equivalents	865,017	310,571
Fair Value, Recurring Basis \| Level 1 \| Treasury bills
Financial Assets:
Cash equivalents	0
Fair Value, Recurring Basis \| Level 2
Financial Assets:
Cash equivalents	164,958	0
Marketable securities	5,001,507	4,325,836
Publicly held equity securities included in strategic investments	0	0
Total financial assets	5,166,710	4,326,108
Fair Value, Recurring Basis \| Level 2 \| Commercial paper
Financial Assets:
Marketable securities	56,098	77,701
Fair Value, Recurring Basis \| Level 2 \| Agency bonds
Financial Assets:
Marketable securities	1,596,783	810,650
Fair Value, Recurring Basis \| Level 2 \| Corporate and other debt securities
Financial Assets:
Marketable securities	586,787	550,894
Fair Value, Recurring Basis \| Level 2 \| U.S. government agency securities
Financial Assets:
Marketable securities	2,711,776	2,861,215
Fair Value, Recurring Basis \| Level 2 \| Treasury bills
Financial Assets:
Marketable securities	50,063	25,376
Fair Value, Recurring Basis \| Level 2 \| Certificates of deposit included in other assets, noncurrent
Financial Assets:
Certificates of deposit included in other assets, noncurrent	245	272
Fair Value, Recurring Basis \| Level 2 \| Privately held debt securities included in strategic investments
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 2 \| Money market funds
Financial Assets:
Cash equivalents	0	0
Fair Value, Recurring Basis \| Level 2 \| Treasury bills
Financial Assets:
Cash equivalents	164,958
Fair Value, Recurring Basis \| Level 3
Financial Assets:
Cash equivalents	0	0
Marketable securities	0	0
Publicly held equity securities included in strategic investments	0	0
Total financial assets	3,791	14,400
Fair Value, Recurring Basis \| Level 3 \| Commercial paper
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 3 \| Agency bonds
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 3 \| Corporate and other debt securities
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 3 \| U.S. government agency securities
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 3 \| Treasury bills
Financial Assets:
Marketable securities	0	0
Fair Value, Recurring Basis \| Level 3 \| Certificates of deposit included in other assets, noncurrent
Financial Assets:
Certificates of deposit included in other assets, noncurrent	0	0
Fair Value, Recurring Basis \| Level 3 \| Privately held debt securities included in strategic investments
Financial Assets:
Marketable securities	3,791	14,400
Fair Value, Recurring Basis \| Level 3 \| Money market funds
Financial Assets:
Cash equivalents	0	$ 0
Fair Value, Recurring Basis \| Level 3 \| Treasury bills
Financial Assets:
Cash equivalents	$ 0

Restructuring Activities - Schedule of Restructuring Reserve (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2023	Jan. 31, 2023
Severance and termination benefits
Restructuring Reserve [Roll Forward]
Restructuring reserve, balance at end of period	$ 0	$ 0
Restructuring expenses	54,361
Cash payments	(54,361)
Other
Restructuring Reserve [Roll Forward]
Restructuring reserve, balance at end of period	0	$ 0
Restructuring expenses	1,339
Cash payments	$ (1,339)

Cover - shares	9 Months Ended
Cover - shares	Oct. 31, 2023	Nov. 10, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2023
Document Transition Report	false
Entity File Number	001-38865
Entity Registrant Name	Zoom Video Communications, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	61-1648780
Entity Address, Address Line One	55 Almaden Boulevard
Entity Address, Address Line Two	6th Floor
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95113
City Area Code	888
Local Phone Number	799-9666
Title of 12(b) Security	Class A Common Stock, $0.001 par value per share
Trading Symbol	ZM
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001585521
Current Fiscal Year End Date	--01-31
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		257,786,492
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		46,637,009

Income Taxes (Tables)

9 Months Ended

Oct. 31, 2023

Income Tax Disclosure [Abstract]

Schedule of Provision for Income Taxes

The following table provides details of the provision for income taxes:


	Three Months Ended October 31,						Nine Months Ended October 31,
	2023			2022			2023			2022

	(in thousands, except percentages)
Income before provision for income taxes	$	185,826		$	54,749		$	479,429		$	288,820
Provision for income taxes	44,614			6,396			140,799			81,059
Effective tax rate	24.0		%	11.7		%	29.4		%	28.1		%

Business Combinations (Details) - USD ($) $ in Thousands			9 Months Ended
Business Combinations (Details) - USD ($) $ in Thousands	Apr. 21, 2023	May 19, 2022	Oct. 31, 2023	Jan. 31, 2023
Business Acquisition [Line Items]
Goodwill			$ 307,295	$ 122,641
Solvvy, Inc.
Business Acquisition [Line Items]
Business acquisition, percentage of voting interests acquired (as a percent)		100.00%
Cash consideration paid		$ 121,200
Goodwill		95,000
Intangible assets, other than goodwill		26,700
Other net liabilities acquired		500
Solvvy, Inc. \| Developed Technology Rights
Business Acquisition [Line Items]
Intangible assets, other than goodwill		$ 12,000
Acquired finite-lived intangible assets, weighted average useful life (in years)		5 years	3 years 6 months
Solvvy, Inc. \| Customer Relationships
Business Acquisition [Line Items]
Intangible assets, other than goodwill		$ 14,700
Acquired finite-lived intangible assets, weighted average useful life (in years)		5 years	3 years 6 months
Workvivo Limited
Business Acquisition [Line Items]
Business acquisition, percentage of voting interests acquired (as a percent)	100.00%
Cash consideration paid	$ 221,800
Goodwill	184,700
Intangible assets, other than goodwill	28,000
Other net assets acquired	9,100
Workvivo Limited \| Developed Technology Rights
Business Acquisition [Line Items]
Intangible assets, other than goodwill	$ 10,800
Acquired finite-lived intangible assets, weighted average useful life (in years)	5 years		4 years 6 months
Workvivo Limited \| Customer Relationships
Business Acquisition [Line Items]
Intangible assets, other than goodwill	$ 17,000
Acquired finite-lived intangible assets, weighted average useful life (in years)	5 years		4 years 6 months

Net Income Per Share Attributable to Common Stockholders

9 Months Ended

Oct. 31, 2023

Earnings Per Share [Abstract]

Net Income Per Share Attributable to Common Stockholders

The following table sets forth the computation of basic and diluted net income per share attributable to common stockholders for the periods presented:


	Three Months Ended October 31,								Nine Months Ended October 31,
	2023				2022				2023				2022
	Class A		Class B		Class A		Class B		Class A		Class B		Class A		Class B
	(in thousands, except share and per share data)
Numerator:
Net income	$	119,429	$	21,783	$	40,726	$	7,627	$	285,778	$	52,852	$	174,835	$	32,926
Less: undistributed earnings attributable to participating securities	—		—		—		—		—		—		—		(17)
Net income attributable to common stockholders, basic	$	119,429	$	21,783	$	40,726	$	7,627	$	285,778	$	52,852	$	174,835	$	32,909
Reallocation of net income attributable to common stockholders	(920)		920		(568)		568		(2,634)		2,634		(2,516)		2,516
Net income attributable to common stockholders, diluted	$	118,509	$	22,703	$	40,158	$	8,195	$	283,144	$	55,486	$	172,319	$	35,425
Denominator:
Weighted-average shares used in computing net income per share attributable to common stockholders, basic	255,832,539		46,660,643		248,917,590		46,619,436		252,365,545		46,672,454		250,595,877		47,169,971
Weighted-average shares used in computing net income per share attributable to common stockholders, diluted	260,488,614		49,901,291		250,803,759		51,182,582		256,573,508		50,278,682		253,217,436		52,056,376
Net income per share attributable to common stockholders, basic	$	0.47	$	0.47	$	0.16	$	0.16	$	1.13	$	1.13	$	0.70	$	0.70
Net income per share attributable to common stockholders, diluted	$	0.45	$	0.45	$	0.16	$	0.16	$	1.10	$	1.10	$	0.68	$	0.68


	Three Months Ended October 31,				Nine Months Ended October 31,
	2023		2022		2023		2022
	Class A	Class B	Class A	Class B	Class A	Class B	Class A	Class B
Unvested RSUs	7,869,069	—	12,741,748	—	9,345,635	—	7,656,321	—
Purchase rights committed under the ESPP	1,573,013	—	2,395,761	—	1,996,477	—	1,462,148	—
Outstanding stock options	102,711	—	124,547	—	111,803	—	75,984	—
Total	9,544,793	—	15,262,056	—	11,453,915	—	9,194,453	—

The table above does not include 405,156 shares of issued Class A common stock held by us as of October 31, 2023 and 2022 that are reserved for the sole purpose of being transferred to nonprofit organizations.

Revenue Recognition (Tables)

9 Months Ended

Oct. 31, 2023

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue by Region

The following table summarizes revenue by region based on the billing address of customers:


	Three Months Ended October 31,								Nine Months Ended October 31,
	2023				2022				2023				2022
	Amount		Percentage of Revenue		Amount		Percentage of Revenue		Amount		Percentage of Revenue		Amount		Percentage of Revenue

	(in thousands, except percentages)
Americas	$	814,311	71.6	%	$	773,576	70.2	%	$	2,407,333	71.2	%	$	2,264,647	69.1	%
Asia Pacific (“APAC”)	143,917		12.7		146,196		13.3		429,703		12.7		444,372		13.6
Europe, Middle East, and Africa (“EMEA”)	178,499		15.7		182,127		16.5		543,731		16.1		566,138		17.3
Total	$	1,136,727	100.0	%	$	1,101,899	100.0	%	$	3,380,767	100.0	%	$	3,275,157	100.0	%

Balance Sheet Components -Schedule of Rollforward of Allowance For Credit Losses (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	$ 24,900	$ 17,000
Provision for credit losses	39,397	34,610
Write-offs	(30,968)	(27,265)
Ending balance	$ 33,329	$ 24,345

Stockholders’ Equity and Equity Incentive Plans - Schedule of Stock Option Activity Under Equity Incentive Plan (Details) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Oct. 31, 2023 USD ($) $ / shares shares	Jan. 31, 2023 USD ($) $ / shares shares
Outstanding Stock Options
Beginning balance (in shares) \| shares	4,800,616
Exercised (in shares) \| shares	(1,214,532)
Cancelled/forfeited/expired (in shares) \| shares	(22,230)
Ending balance (in shares) \| shares	3,563,854	4,800,616
Exercisable (in shares) \| shares	3,563,854
Weighted- Average Exercise Price
Beginning balance (in dollars per share) \| $ / shares	$ 8.22
Exercised (in dollars per share) \| $ / shares	6.86
Cancelled/forfeited/expired (in dollars per share) \| $ / shares	92.95
Ending balance (in dollars per share) \| $ / shares	8.16	$ 8.22
Weighted average exercise price, exercisable (in dollars per share) \| $ / shares	$ 8.16
Weighted- Average Remaining Contractual Life (Years)
Outstanding (in years)	4 years 1 month 6 days	4 years 10 months 24 days
Weighted-average remaining contractual life, exercisable (in years)	4 years 1 month 6 days
Aggregate Intrinsic Value
Outstanding \| $	$ 188,163	$ 322,929
Exercised \| $	75,266
Aggregate intrinsic value, exercisable \| $	$ 188,163

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Income Statement [Abstract]
Revenue	$ 1,136,727	$ 1,101,899	$ 3,380,767	$ 3,275,157
Cost of revenue	270,988	270,665	801,494	806,097
Gross profit	865,739	831,234	2,579,273	2,469,060
Operating expenses:
Research and development	196,832	195,946	597,905	512,801
Sales and marketing	374,378	427,747	1,170,255	1,191,004
General and administrative	125,140	141,033	454,364	389,939
Total operating expenses	696,350	764,726	2,222,524	2,093,744
Income from operations	169,389	66,508	356,749	375,316
(Losses) gains on strategic investments, net	(25,471)	(6,898)	8,474	(78,014)
Other income (expense), net	41,908	(4,861)	114,206	(8,482)
Income before provision for income taxes	185,826	54,749	479,429	288,820
Provision for income taxes	44,614	6,396	140,799	81,059
Net income	141,212	48,353	338,630	207,761
Undistributed earnings attributable to participating securities	0	0	0	(17)
Net income attributable to common stockholders	$ 141,212	$ 48,353	$ 338,630	$ 207,744
Net income per share attributable to common stockholders:
Basic (in dollars per share)	$ 0.47	$ 0.16	$ 1.13	$ 0.70
Diluted (in dollars per share)	$ 0.45	$ 0.16	$ 1.10	$ 0.68
Weighted-average shares used in computing net income per share attributable to common stockholders:
Basic (in shares)	302,493,182	295,537,026	299,037,999	297,765,848
Diluted (in shares)	310,389,905	301,986,341	306,852,190	305,273,812